Clinical Trial Update: Hypoglycemia Counterregulation and Symptom Perception With Insulin Detemir [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating hypoglycemia counterregulation and symptom perception in diabetes patients treated with insulin detemir has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hypoglycemia

Drugs mentioned

• Insulin detemir (insulin detemir)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Diabetes Mellitus, Hypoglycemia | Phase 4 | Status: TERMINATED